Twist Bioscience Corp
TWST
Market Cap$1.76B
Close$
$42.26
36.1% upside
Current Fair Value
36.1% upsideUndervalued by 36.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.76 Billion |
|---|---|
| Enterprise Value | $1.63 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.6 |
| Beta | 2.54 |
| Outstanding Shares | 59,649,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -9.14 |
|---|---|
| PEG | 67.48 |
| Price to Sales | 6.21 |
| Price to Book Ratio | 4.44 |
| Enterprise Value to Revenue | 4.67 |
| Enterprise Value to EBIT | -10.83 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Twist Bioscience Corp
CEO: Emily Leproust Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary techno...